Dynavax Technologies Corporation (LON:0IDA)
10.39
+0.49 (4.94%)
At close: Aug 11, 2025
Chuy's Holdings Revenue
Dynavax Technologies had revenue of $95.44M USD in the quarter ending June 30, 2025, with 29.33% growth. This brings the company's revenue in the last twelve months to $316.27M, up 26.66% year-over-year. In the year 2024, Dynavax Technologies had annual revenue of $277.25M with 19.36% growth.
Revenue (ttm)
$316.27M
Revenue Growth
+26.66%
P/S Ratio
4.05
Revenue / Employee
$780.91K
Employees
405
Market Cap
935.05M
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 277.25M | 44.96M | 19.36% |
Dec 31, 2023 | 232.28M | -490.40M | -67.86% |
Dec 31, 2022 | 722.68M | 283.24M | 64.45% |
Dec 31, 2021 | 439.44M | 399.19M | 991.75% |
Dec 31, 2020 | 40.25M | 5.03M | 14.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
Oxford Nanopore Technologies | 183.19M |
HUTCHMED (China) | 439.54M |
Dynavax Technologies News
- 6 days ago - Dynavax Technologies Corporation 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 6 days ago - Dynavax raises 2025 HEPLISAV-B revenue guidance to $315M-$325M and targets 60% U.S. market share by 2030 as retail momentum grows - Seeking Alpha
- 6 days ago - Dynavax Technologies Corporation (DVAX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Dynavax (DVAX) Q2 Revenue Jumps 29% - The Motley Fool
- 6 days ago - Dynavax Reports Second Quarter 2025 Financial Results - PRNewsWire
- 15 days ago - Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - PRNewsWire
- 2 months ago - Dynavax re-elects all board members, despite Deep Capital's push to change - Seeking Alpha
- 2 months ago - Dynavax elects all four of its nominees after Deep Track proxy fight - Reuters